TechnoPhage, SA - From science to innovative biopharmaceuticals
New patent granted to TechnoPhage/Lusomedicamenta Title: Antibacterial Phage, Phage Peptides and Methods of Use Thereof Office: United States Patent and Trademark Office Date: 22/10/2013 Patent no: US 8,563,504 B2
New patent granted to TechnoPhage: Title: Engineered Rabbit Antibody Variable Domains and Uses Thereof Office: The Registry of Patents Singapore Date: 11/10/2013 Patent no: 156768 [WO 2008/136694]
TechnoPhage invited to present Rheumatoid Arthritis therapeutics development programme at National Association of Rheumatoid Arthritis Patients (ANDAR) Symposium - "Disclosing the future in RA: the Portuguese contribution" at Gulbenkian Foundation, Lisboa, Portugal.
TechnoPhage invited to present at the National Symposium of Portuguese Association of the Pharmaceutical Industry - APIFARMA: "O Valor da Inovação: Da Investigação ao Doente" at Centro Cultural de Belém, Lisbon, Portugal. Seminar Title: "Desafios da Teraêutica Inovadora no séc. XXI".

2019 events

18th Fraunhofer Seminar "Models of Lung Disease"
Hannover, Germany. January 24 - 25, 2019

Phage Futures Congress
Washington DC. January 29-30, 2019

Bacteriophage Therapy Summit
Boston, MA. March 26-27, 2019

29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
Amsterdam, Netherlands. April 13-16, 2019